|Project Title||Sentinel Initiative Public Workshop - Fourth Annual|
Tuesday, January 17, 2012
The Engelberg Center for Health Care Reform at Brookings hosted the Fourth Annual Sentinel Initiative Public Workshop on Wednesday, January 18, at the Washington Marriott in Washington, DC. This public workshop brought together the stakeholder community for a productive discussion on a variety of topics in active medical product surveillance, including an update on the U.S. Food and Drug Administration’s (FDA’s) Sentinel Initiative; efforts to support the advancement of safety science; and stakeholder perspectives on the Sentinel Initiative’s progress and future direction.
Dr. Stephen Spielberg, the FDA’s newly appointed Deputy Commissioner for Medical Products and Tobacco, provided the morning keynote address.
Mark McClellan MD, PhD; Engelberg Center for Health Care Reform, Brooking Institution, Washington DC
Stephen Speilberg MD, PhD,;U.S. Food and Drug Administration, Silver Spring, MD
Rachel Sherman MD; U.S. Food and Drug Administration, Silver Spring, MD
Richard Platt MD, MSc; Department of Population Medicine, Harvard Pilgrim Healthcare Institute and Harvard Medical School, Boston, MA
Robert Temple MD; U.S. Food and Drug Administration, Silver Spring, MD
Ed Staffa; U.S. Food and Drug Administration, Silver Spring, MD